Our findings add a new twist to this mystery as we reveal that RAS at the GC, which includes H- and N- isoforms but not KRAS, actually antagonize tumor formation through induction of PTPRκ that downregulates ERK activity, the engine at the heart of RAS transformation. This evidence concerns the gene KRAS and neoplasm.